Authors:
Naumann, M
Giess, R
Schwager, K
Toyka, KV
Citation: M. Naumann et al., Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach - Reply, J NE NE PSY, 70(3), 2001, pp. 418-418
Authors:
Ochs, G
Penn, RD
York, M
Giess, R
Beck, M
Tonn, J
Haigh, J
Malta, E
Traub, M
Sendtner, M
Toyka, KV
Citation: G. Ochs et al., A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophiclateral sclerosis, AMYOTROPH L, 1(3), 2000, pp. 201-206
Authors:
Maurer, M
Kruse, N
Giess, R
Toyka, KV
Rieckmann, P
Citation: M. Maurer et al., Genetic variation at position-1082 of the interleukin 10 (IL10) promotor and the outcome of multiple sclerosis, J NEUROIMM, 104(1), 2000, pp. 98-100
Authors:
Giess, R
Beck, M
Goetz, R
Nitsch, RM
Toyka, KV
Sendtner, M
Citation: R. Giess et al., Potential role of LIF as a modifier gene in the pathogenesis of amyotrophic lateral sclerosis, NEUROLOGY, 54(4), 2000, pp. 1003-1005
Authors:
Giess, R
Naumann, M
Werner, E
Riemann, R
Beck, M
Puls, I
Reiners, C
Toyka, KV
Citation: R. Giess et al., Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis, J NE NE PSY, 69(1), 2000, pp. 121-123
Authors:
Maurer, M
Kruse, N
Giess, R
Kyriallis, K
Toyka, KV
Rieckmann, P
Citation: M. Maurer et al., Gene polymorphism at position-308 of the tumor necrosis factor alpha promotor is not associated with disease progression in multiple sclerosis patients, J NEUROL, 246(10), 1999, pp. 949-954
Authors:
Beck, M
Giess, R
Wurffel, W
Magnus, T
Ochs, G
Toyka, KV
Citation: M. Beck et al., Comparison of maximal voluntary isometric contraction and Drachman's hand-held dynamometry in evaluating patients with amyotrophic lateral sclerosis, MUSCLE NERV, 22(9), 1999, pp. 1265-1270